Minimising patient non-adherence


Detailed report available on NICE's proposals for value based assessment of health technologies

Value Based Assessment
The risk of non-adherence can be minimised by ensuring that the patient is fully involved in the decisions about their treatment.  One of the most important times is when a new medicine has been prescribed.  Patients need to understand about the medicine and how it will affect them and their condition.  The best time to provide this information is at the time of prescribing.  However, this may not be possible or practical, especially if their is limited time or the patient has been informed about a new diagnosis.

Pharmacists are increasingly being used to provide information about newly prescribed medicines, address concerns that the patient has about their medicines and help the patient with the practical aspects of medicine taking.  They can play an important part in minimising the risk of patient non-adherence.

See for an article on minimising the risk of non-adherence or Click here to download article
Contact us

Contact PruceConsulting by e-mailing through the link below or by calling the number below

Phone: +44 (0)7704 188146